Diclegis® is accessible and affordable

We make it easy for you to write Diclegis®

There are several ways to help you provide Diclegis® to all your patients. Even without prescription drug insurance or coverage for Diclegis®, your patients could pay as little as $1 per tablet.

My patient has commercial insurance and Diclegis® is covered

Use the Copay Savings Card

With this card, most patients could pay as little as
$40* for a prescription of Diclegis®

Patients simply show the Copay Savings Card information below to their pharmacist:

copay information

  • The code may be entered manually when patients pick up their prescription to ensure that they pay the lowest price.
  • Have an EMR system? Simply add the Copay information above to your system and the universal code can be used for all your Diclegis® patients.

Click to download and print your Copay Savings Card.

Download

Make sure your patient’s pharmacist has entered your code so that she pays the lowest price!

If you have any questions about the Diclegis® Savings card, please call 1-800-250-5195.

*See offer for terms and conditions.

My patient doesn’t have insurance or Diclegis® is not covered by their insurance

Foundation Care ships right to your patient’s home!

With Foundation Care, patients can receive Diclegis® for just
$1 per tablet!

  • 60 tablets for $60, plus $10 shipping
  • 90 tablets for $90, free shipping
  • 120 tablets for $120, free shipping

Prescribe Diclegis® through Foundation Care Pharmacy, Earth City, MO 63015 (NABP/NCPDP Provider ID: 2635564)

Fax, call in or e-prescribe now!

Download the instructions and order form.

Download

fc logo

If you have any questions, please call the Foundation Care Pharmacy at 1-877-291-1122

Indication and Important Safety Information

INDICATION

Diclegis® is a fixed-dose combination drug product of doxylamine succinate, an antihistamine, and pyridoxine hydrochloride, a vitamin B6 analog, indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.

LIMITATIONS OF USE

Diclegis® has not been studied in women with hyperemesis gravidarum.

IMPORTANT SAFETY INFORMATION

Diclegis® is contraindicated in women with known hypersensitivity to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride, or any inactive ingredient in the formulation. Diclegis® is also contraindicated in combination with monoamine oxidase inhibitors (MAOIs) as MAOIs intensify and prolong the adverse CNS effects of Diclegis®. Use of MAOIs may also prolong and intensify the anticholinergic (drying) effects of antihistamines.

Diclegis® may cause somnolence due to the anticholinergic properties of doxylamine succinate, an antihistamine. Women should avoid engaging in activities requiring complete mental alertness, such as driving or operating heavy machinery, while using Diclegis® until cleared to do so by their healthcare provider.

Use of Diclegis® is not recommended if a woman is concurrently using CNS depressants, such as alcohol or sedating medications, including other antihistamines (present in some cough and cold medications), opiates, and sleep aids. The combination of Diclegis® and CNS depressants could result in severe drowsiness leading to falls or other accidents.

Diclegis® has anticholinergic properties and should be used with caution in women who have: (1) asthma, (2) increased intraocular pressure, (3) an eye problem called narrow angle glaucoma, (4) a stomach problem called stenosing peptic ulcer, (5) pyloroduodenal obstruction, or (6) a urinary bladder problem called bladder-neck obstruction.

Fatalities have been reported from doxylamine overdose in children. Children appear to be at a high risk for cardiorespiratory arrest. However, the safety and effectiveness of Diclegis® in children under 18 years of age have not been established.

Diclegis® is a delayed-release formulation; therefore, signs and symptoms of intoxication may not be apparent immediately. Signs and symptoms of overdose may include restlessness, dryness of mouth, dilated pupils, sleepiness, vertigo, mental confusion, and tachycardia. If you suspect an overdose or seek additional overdose information, you can contact a poison control center at 1-800-222-1222.

Diclegis® is intended for use in pregnant women.

Women should not breast-feed while using Diclegis® because the antihistamine component (doxylamine succinate) in Diclegis® can pass into breast milk. Excitement, irritability, and sedation have been reported in nursing infants presumably exposed to doxylamine succinate through breast milk. Infants with apnea or other respiratory syndromes may be particularly vulnerable to the sedative effects of Diclegis® resulting in worsening of their apnea or respiratory conditions.

To report suspected adverse reactions, contact Duchesnay Inc. at 1-855-722-7734 or medicalinfo@duchesnayusa.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Tablet(s) shown throughout the site are not actual size.

 

Please click here for full Prescribing Information.

 

Site references

  1. Diclegis® Prescribing Information, Bryn Mawr, PA: Duchesnay USA Inc., 2013.
  2. Whitehead, S. A., et al. (1992). “Characterisation of nausea and vomiting in early pregnancy: a survey of 1000 women.” J Obstet Gynecol 12(6): 364-369.
  3. Gadsby, R., et al. (1993). “A prospective study of nausea and vomiting during pregnancy.” Br J Gen Pract 43(371): 245-248.
  4. Vellacott, I. D., et al. (1988). “Nausea and vomiting in early pregnancy.” Int J Gynecol Obstet 27(1): 57-62.
  5. Nausea and Vomiting of Pregnancy, ACOG Practice Bulletin #153: Clinical Management Guidelines for Obstetrician-Gynecologists 2015; 126, 3:e12-e24.
  6. Association of Professors of Gynecology and Obstetrics Continuing Series on Women’s Health: Nausea and Vomiting of Pregnancy, February 2015.
  7. McKeigue, P. M., et al. (1994). “Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies.” Teratology 50: 27-37.

eVoucherRx™ Program

As a participant in the eVoucherRx Program powered by RelayHealth, Duchesnay USA has made it possible to extend prescription savings on to you. eVoucherRx is a paperless electronic coupon program that makes co-pay savings on your prescription for Diclegis® easy for physicians, patients and pharmacists.

Participating Pharmacies

Patients simply take your eligible prescription for Diclegis® to a participating pharmacy and the eVoucherRx savings coupon will be automatically applied to your co-pay.

Find an eVoucherRx™ pharmacy in your area:

The eVoucherRx™ program, powered by RelayHealth, provides electronic coupons to help reduce a patient's out-of-pocket cost on selected products. Participating pharmacies are subject to change without notice.

evoucherrx.relayhealth.com/StoreLookup